Carregant...
Bevacizumab or laser for aggressive posterior retinopathy of prematurity
PURPOSE: The purpose of this study was to report the rate of reactivation and structural outcome, after the laser or bevacizumab treatment for aggressive posterior retinopathy of prematurity (APROP). METHODS: Retrospective chart review was conducted on consecutive infants with APROP treated with (1)...
Guardat en:
| Publicat a: | Taiwan J Ophthalmol |
|---|---|
| Autors principals: | , , , , , , |
| Format: | Artigo |
| Idioma: | Inglês |
| Publicat: |
Medknow Publications & Media Pvt Ltd
2018
|
| Matèries: | |
| Accés en línia: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6302568/ https://ncbi.nlm.nih.gov/pubmed/30637196 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.4103/tjo.tjo_69_18 |
| Etiquetes: |
Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!
|